The new standard of HCV therapy: Treatment in therapy-naive patients
| dc.contributor.author | Agrawal, Saurabh | |
| dc.contributor.author | Kwo, Paul Y. | |
| dc.contributor.department | Medicine, School of Medicine | en_US |
| dc.date.accessioned | 2019-08-23T18:31:44Z | |
| dc.date.available | 2019-08-23T18:31:44Z | |
| dc.date.issued | 2012-03-06 | |
| dc.identifier.citation | Agrawal, S., & Kwo, P. Y. (2012). The new standard of HCV therapy: Treatment in therapy-naive patients. Clinical liver disease, 1(1), 12–15. doi:10.1002/cld.7 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/20554 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Wiley | en_US |
| dc.relation.isversionof | 10.1002/cld.7 | en_US |
| dc.relation.journal | Clinical Liver Disease | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.source | PMC | en_US |
| dc.subject | Hepatitis C virus (HCV) | en_US |
| dc.subject | Pegylated interferon | en_US |
| dc.subject | Ribavirin | en_US |
| dc.subject | Nonstructural 3 protease inhibitors | en_US |
| dc.subject | Telaprevir (TVR) | en_US |
| dc.subject | Boceprevir (BOC) | en_US |
| dc.title | The new standard of HCV therapy: Treatment in therapy-naive patients | en_US |
| dc.type | Article | en_US |
| ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490699/ | en_US |